Intimation Regarding Execution Of Agreement By Wholly Owned Subsidiary Of The Company
Filed with BSE · · 2 pages · English
Summary by 6ix AI
The project will focus on developing various pharmaceutical forms, including pellets, granules, powders, tablets, and capsules. The estimated cost for this project is significant, and Mrs. Chaitali Shah has been authorized to execute the agreement and manage related activities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/intimation-regarding-execution-of-agreement-by-wholly-owned-subsidiary-of-the-company
Earlier from Bacil Pharma
- Un-Audited Financial Result For The Quarter And Half Yearly Ended 30Th September, 2026
- Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th October, 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Board Meeting Intimation for We Wish To Inform That The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Wednesday, 14Th October, 2026
- Bacil Pharma Ltd Press Release Sep 26 2026
Follow Bacil Pharma into a list and get an email when it puts out news.
Follow Bacil Pharma